Following the recent announcement by the Ministry of Health (MINCA) about the increase in cases Omigron variant In the country, thousands of doubts have been raised about the doses of vaccines in the country. Are they effective or not? Do they protect or not? How many reinforcements will people need?
Currently 71 cases have been detectedTherefore, the health agency has asked citizens not to reduce their safety. In this note we tell you everything you need to know about this new generation.
What are the symptoms of the Omigron variant?
According to the World Health Organization (WHO), the Omigran variant causes mild symptoms, but it is still being studied. In addition, the United Kingdom confirmed the first death from this lineage, causing re-infection.
One month after its discovery in South Africa, studies shed more light on this new generation, which is more contagious in the delta and less violent, although the latter is believed to be responsible for the improvement of the vaccine.
“Although Omigron causes less severe symptoms, the number of patients may again overwhelm health systems that are not ready,” warned Tetros Adonom Caprais, director general of the World Health Organization (WHO).
According to Godofredo Talavera, President of the Peruvian Medical Association (FMP) Symptoms: Headache, headache, Throat discomfort, Muscle aches Y General discomfort.
Are the currently used vaccines in Peru effective?
The WHO has indicated that the Omigran variant does not cause more serious disease than the already known lineages, so all vaccines may be effective in counteracting the impact of COVID-19 on health. However, according to recent studies, mutations Omigron SARS-CoV-2 appears to weaken the immunity of antibodies against the corona virus, so it can spread among many vaccinated people (and even re-infect some).
“We have the most effective vaccines that have so far proven their power against all variants based on the severity of the disease and hospitalization, and there is no reason to think that this will not be the case (with Omigran),” he said. Michael Ryan, WHO Representative.
Numerous laboratory studies have shown that the antibody rate decreases to omigran between Pfizer / Bioentech, Moderna, and those receiving the low estrogen or Sinovac vaccine.
To date, it is believed that a booster dose appears to boost antibody immunity. At least different labs have reported this: Pfizer / BioNTech, Moderna and AstraZeneca, but it remains to be seen how long that effect will last.
As for the synoform vaccine used in Peru, there are no definitive studies yet to determine the low efficacy against this new generation. In this regard, Minza clarified that these doses helped save lives, but the third doses used for the population were Pfizer and Astrogeneca.
You can see: Minza confirms 71 cases of Omigron variant in Peru
What steps can be taken to prevent it?
Health officials recommend using your two-dose vaccine COVID-19. Citizens are urged to use their booster dose, avoid crowded places, wear a double mask or KN95 and maintain a social space.
Are Omigran cases detected in Peru?
Yes, as of December 26, 71 cases of this new type of virus have been detected in the country. The patient with this new lineage entered Peru from a trip to zero South Africa.
Health Minister Hernando Sevalos said of the 49 cases known as of Sunday morning, 19 had been added, nine in metropolitan Lima and three in Sullana.
In the total number of cases detected Omigron variant Located in the national territory, 67 are in metropolitan Lima and Callo. However, in the words of Sevalos Florus, “there may be more omigran infections to be confirmed.”
“We may have omigran infections. You know, the incidence of omigran variants is twice as high as the variants we had. I’m in contact with the regional health director so they can take all necessary measures to prevent it from spreading further in the bureau,” he said.